Vectorbuilder

Vectorbuilder company information, Employees & Contact Information

Explore related pages

Related company profiles:

As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received glowing customer testimonials and numerous citations in high-impact publications. Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served over 50,000 customers from several thousand organization worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies. So we ask you one question: Will you join us in the gene delivery revolution?

Company Details

Employees
95
Founded
-
Address
1010 W 35th St, Suite 515,china
Phone
+1 800-517-2189
Email
se****@****der.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Chicago, Illinois
Looking for a particular Vectorbuilder employee's phone or email?

Vectorbuilder Questions

News

VectorBuilder Wins Two IMAPAC Awards, Cementing Leadership in Gene Therapy and CDMO Innovation - Business Wire

VectorBuilder Wins Two IMAPAC Awards, Cementing Leadership in Gene Therapy and CDMO Innovation Business Wire

VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Product - Yahoo Finance

VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Product Yahoo Finance

VectorBuilder Wins BioIndustrial Innovation of the Year Award - Business Wire

VectorBuilder Wins BioIndustrial Innovation of the Year Award Business Wire

VectorBuilder To Invest $30 Million To Build the World’s First "AAV Superbank" - Technology Networks

VectorBuilder To Invest $30 Million To Build the World’s First "AAV Superbank" Technology Networks

Biotech unicorn VectorBuilder eyes future gene delivery advances - drugdiscoverytrends.com

Biotech unicorn VectorBuilder eyes future gene delivery advances drugdiscoverytrends.com

VectorBuilder raises $57m in China for gene therapy delivery - BioProcess International

VectorBuilder raises $57m in China for gene therapy delivery BioProcess International

VectorBuilder bags $57M to build out gene delivery capabilities - Fierce Pharma

VectorBuilder bags $57M to build out gene delivery capabilities Fierce Pharma

Functional BRI2-TREM2 interactions in microglia: implications for Alzheimer’s and related dementias - EMBO Press

Functional BRI2-TREM2 interactions in microglia: implications for Alzheimer’s and related dementias EMBO Press

Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth - ScienceDirect.com

Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth ScienceDirect.com

Development and characterization of a non-human primate model of disseminated synucleinopathy - Frontiers

Development and characterization of a non-human primate model of disseminated synucleinopathy Frontiers

Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation - Nature

Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation Nature

Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials - Business Wire

Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials Business Wire

VectorBuilder's ethical focus reshapes gene delivery - drugdiscoverytrends.com

VectorBuilder's ethical focus reshapes gene delivery drugdiscoverytrends.com

VectorBuilder to spend $500M to construct gene therapy manufacturing site in China - Fierce Pharma

VectorBuilder to spend $500M to construct gene therapy manufacturing site in China Fierce Pharma

VectorBuilder and Landau To Establish World’s First Primate Gene Therapy R&D Center - Technology Networks

VectorBuilder and Landau To Establish World’s First Primate Gene Therapy R&D Center Technology Networks

VectorBuilder and Landau join forces to create primate gene therapy research center - drugdiscoverytrends.com

VectorBuilder and Landau join forces to create primate gene therapy research center drugdiscoverytrends.com

VectorBuilder’s Chief Scientist, Dr. Bruce Lahn Named to the 2024 PharmaVoice 100 - Business Wire

VectorBuilder’s Chief Scientist, Dr. Bruce Lahn Named to the 2024 PharmaVoice 100 Business Wire

VectorBuilder Supports First Gene Therapy Trial for Menkes Disease - Technology Networks

VectorBuilder Supports First Gene Therapy Trial for Menkes Disease Technology Networks

VectorBuilder Redefines Plasmid Standards with miniVec - Business Wire

VectorBuilder Redefines Plasmid Standards with miniVec Business Wire

VectorBuilder Expands Global Reach with UK Headquarters - Business Wire

VectorBuilder Expands Global Reach with UK Headquarters Business Wire

Channels at the Nodes of Ranvier for Rapid Action Potential Conduction on Mammalian Myelinated Afferent Nerves - ScienceDirect.com

Channels at the Nodes of Ranvier for Rapid Action Potential Conduction on Mammalian Myelinated Afferent Nerves ScienceDirect.com

Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease - ScienceDirect.com

Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease ScienceDirect.com

Stand Up Therapeutics Signed with VectorBuilder for World's First Gene Therapy Supply for Paraplegia Patient - PR Newswire

Stand Up Therapeutics Signed with VectorBuilder for World's First Gene Therapy Supply for Paraplegia Patient PR Newswire

Thanks to collaboration between Stand Up Therapeutics and VectorBuilder, a paraplegic patient will get gene therapy for the first time - Business Standard

Thanks to collaboration between Stand Up Therapeutics and VectorBuilder, a paraplegic patient will get gene therapy for the first time Business Standard

Top Vectorbuilder Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant